Actively Recruiting

Age: 6Years - 60Years
All Genders
ID07329673

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

Led by Qbtech AB · Updated on 2026-05-06

300

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the performance of QbMobile, a digital software application, in children, adolescents, and adults aged 6 to 60 years who are assessed for or diagnosed with Autism Spectrum Disorder (ASD), Major Depressive Disorder (MDD), Bipolar Disorder, or various Anxiety Disorders. The study aims to identify specific symptom profiles common with ADHD by collecting objective data through QbMobile tests. Participants must not currently be receiving treatment for these conditions. Participants will complete two 10-minute QbMobile tests that measure cognitive performance and activity levels. The first test is done on a personal device during a clinical visit, and the second test is completed remotely the following day at the same time as the initial test, with a three-hour window allowed. QbMobile testing occurs before any new treatment begins and is non-invasive. During the study, participants undergo assessments at two visits: one in-clinic and one remote. Researchers collect data from the QbMobile tests to analyze domain profiles, classification accuracy, and variability using scores such as domain SD-scores and a total score ranging from 0 to 100. These measures help differentiate symptom profiles related to the included disorders. The study also compares results with normative datasets and includes exploratory analyses. Participation lasts until both tests are completed, with close monitoring of test performance.

CONDITIONS

Brief Title

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

Who Can Participate

Age: 6Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Provide written informed consent (including parent/legal guardian consent for individuals under 18 and participant assent as required)
  • Aged over 6 years and under 60 years
  • Referred for initial assessment or diagnosed with ASD, MDD, Bipolar Disorder, or Anxiety Disorders (Separation Anxiety Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder) but not currently receiving treatment
  • Meets DSM-5 or ICD-11 criteria for primary diagnosis of the included disorders
  • Have adequate sensory and physical ability to complete QbMobile
  • Possess or have access to a compatible iPhone model that supports QbMobile
Not Eligible

You will not qualify if you...

  • Intellectual disability with IQ below 70
  • Diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, psychotic disorder due to another medical condition, PTSD, antisocial personality disorder, or borderline personality disorder
  • Primary diagnosis of ADHD (any presentation)
  • Concurrent medical conditions affecting test performance (e.g., brain injuries, Parkinson's disease, epilepsy, ALS, multiple sclerosis, dementias)
  • Conditions affecting test performance such as migraine or severe headache, chronic or acute pain
  • Use of prescription medications that could affect test performance on the day before testing
  • Substance use (alcohol, drugs) that may affect test performance on test days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) during a scheduled clinical appointment

Diagnostic Evaluation

Duration - 1 day

Participants complete the 10-minute QbMobile test on their personal device during a scheduled clinical visit to assess cognitive performance related to ADHD symptoms.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants repeat the 10-minute QbMobile test remotely at home the following day at approximately the same time as the previous test.

1 remote visit

Trial Site Locations

Total: 1 location

1

CCM Clinical Research Group

Miami, Florida, United States, 33133

Actively Recruiting

Loading map...

Research Team

R

Robert Nolen

R

Ragini Sanyal

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

6

Similar Trials

Fasedienol Nasal Spray for Acute Anxiety Treatment in Adults...

Social Anxiety Disorder

Actively Recruiting

9 locations

The Effect of a Transdiagnostic, Self-guided Internet Interv...

Panic Disorder With Agoraphobia

Actively Recruiting

1 location

A Randomized Controlled Trial of the Launching! to Adulthood...

Autism Spectrum Disorder (ASD)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here